[Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy]
- PMID: 15200893
[Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy]
Abstract
Objective: To explore the role of interleukin-1 receptor antagonist (IL-1Ra) in suppression of cartilage matrix degradation and pathologic changes.
Methods: Thirty New Zealand White rabbits underwent partial synovectomy of the left knee. Synovial fibroblasts were isolated and cultured. The rabbits underwent anterior cruciate ligament transection (ACLT) in the right knee. After the ACLT the rabbits were forced to run 4 hours a day for 4 weeks so as to establish the osteoarthritis (OA) model. Three days after the ACLT the rabbits were randomly divided into 3 groups of 10 rabbits: group 1, to be injected with the cultured autologous synovial fibroblasts into the right knees; group 2, injected with the autologous synovial fibroblasts transfected with marker gene, and group 3, injected with autologous synovial fibroblasts transfected with IL-1Ra gene. Two and 4 weeks after the injection 5 rabbits in each group were killed respectively. Their right knee joints were lavaged and the lavage fluid was extracted. IL-1Ra level in the synovial fluid (SF) was determined by ELISA. 20 mg of articular cartilage were taken from the condyle of right femur and digested by papain. The glycosamino-glycan (GAG) level in the SF and in the cartilage digest were evaluated using dimethylmethylene blue assay. Two pieces of cartilage were taken from each rabbit's and were sliced and stained to undergo pathologic changes.
Results: The IL-1Ra level in the SF of the group 3 was (20.2 +/- 1.8) ng/ml 2 weeks after, and was (4.8 +/- 0.5) ng/ml 4 weeks after, significantly lower than those in the group 2 (84 +/- 7) micro g/ml and group 3 (84 +/- 6) micro g/ml IL-1Ra was not detected in the SF of the group 1. The GAG level in SF was 40.1 micro g/ml with an inhibitory rate of 56.2%, and those in the group 2 and group 3 were 30.2 micro g/mg and 10.8 micro g/mg respectively. The GAG levels 4 weeks after in the cartilage digest of the group 1 and group 2 were (10.1 +/- 1.2) micro g/mg and (10.8 +/- 0.9) micro g/mg respectively, both significantly lower than that in the group 3 [(30 +/- 3) micro g/mg, both P < 0.05]. Pathological examination showed that the articular cartilage of the left knee was all normal in all the rabbits. However, obvious damage was found in the articular cartilage of the right knees of all the rabbits. However, the damage in the group 3 was significantly milder than that in the other 2 groups.
Conclusion: Intraartilcular injection of synovial cells transfected with IL-1Ra gene can suppress articular cartilage matrix degradation and pathologic changes.
Similar articles
-
Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.Chin Med J (Engl). 2006 Aug 20;119(16):1365-73. Chin Med J (Engl). 2006. PMID: 16934183
-
Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10.J Orthop Res. 2004 Jul;22(4):742-50. doi: 10.1016/j.orthres.2003.12.007. J Orthop Res. 2004. PMID: 15183429
-
[In vitro effect of alendronate on chondrocytes and articular cartilage and subchondral bone in rabbit anterior cruciate ligament transection model].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009 Dec;23(12):1474-81. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009. PMID: 20073314 Chinese.
-
Osteoarthritis gene therapy.Gene Ther. 2004 Feb;11(4):379-89. doi: 10.1038/sj.gt.3302196. Gene Ther. 2004. PMID: 14724685 Review.
-
Interleukin-1 receptor antagonist gene therapy for arthritis.Curr Opin Mol Ther. 1999 Aug;1(4):454-7. Curr Opin Mol Ther. 1999. PMID: 11713759 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical